Back to Journals ClinicoEconomics and Outcomes Research Volume 18 Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective Authors Torre E , Di Matteo S, Martinotti C , Bruno GM , Cabrino A, Fogliati EL, Giusti A, Barbieri M, Bottaro LC, Colombo GL Received 10 December 2025 Accepted for publication 28 March 2026 Published 1 May 2026 Volume 2026:18 585328 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Samer Hamidi Enrico Torre, 1 Sergio Di Matteo, 2 Chiara Martinotti, 2 Giacomo Matteo Bruno, 3 Alessandro Cabrino, 2 Emma Lucia Fogliati, 2 Andrea Giusti, 4 Marco Barbieri, 5 Luigi Carlo Bottaro, 6 Giorgio Lorenzo Colombo 3 1 Diabetology and Metabolic Diseases Unit, ASL3 Genoa, Genoa, Italy
[2] When to Seek Further Medical Advice About B12 Patients should maintain regular contact with their GP or healthcare team throughout B12 treatment, but certain situations warrant urgent medical review
without a substantial foundation how do we effectively communicate the positive contribution made by spatial planning and those that practice it in the face of such powerful forces
Peptides act as cellular messengers, signaling your body to improve processes like fat metabolism, muscle recovery, hormone regulation, inflammation control, and overall vitality
This shows that current studies still do not have definitive data in relation to GLP-1 RA medications and risk assessments for clear guidelines in the management of these patients perioperatively
Serious reactions are uncommon, and a consultation helps identify anyone who should hold off or be monitored more closely
